IceCure Medical to Report Second Quarter 2023 Financial & Operational Results on August 14, 2023

CAESAREA, Israel, Aug. 7, 2023 /PRNewswire/ — IceCure Medical Ltd. (Nasdaq: ICCM) (“IceCure” or the “Company”), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced…

About the Author

has written 39480 stories on this site.

Copyright © 2010 Business and Corporate News.